ArticleCell communication and signaling : CCS2026
Lipid droplet-mediated macrophage reprogramming drives fibroblast activation in keloid-associated inflammation.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mitochondrial Transplantation Suppresses mtDNA-cGAS/STING-Mediated Innate Immunity by Enhancing PINK1/Parkin-Dependent Mitophagy to Attenuate Keloid Fibrosis.Antioxidants (Basel, Switzerland) · 2026Article
- Potential Causal Association Between Plasma Lipidomes and Keloid: Analysis from a Two-Sample Mendelian Randomization.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundKeloids are fibroproliferative skin disorders characterized by excessive collagen deposition and persistent inflammation. Clinical observations reveal their predominant occurrence in sebaceous gland-rich anatomical regions and frequent association with folliculitis, suggesting a potential role for lipid-enriched microenvironments in disease development. However, the molecular mechanisms linking lipid exposure to immune dysregulation in keloid pathogenesis remain poorly understood.
objectivesThis study aimed to investigate how lipid accumulation influences macrophage activation and subsequent fibroblast responses in keloid-associated inflammation.
methodsWe integrated single-cell RNA sequencing analysis of normal skin, folliculitis, and keloid samples with comprehensive in vitro macrophage-sebocyte co-culture systems and in vivo sebaceous gland hyperplasia models to characterize lipid-mediated immune responses.
resultsSingle-cell transcriptomic analysis revealed distinct macrophage populations with enhanced lipid metabolism signatures in both folliculitis and keloid samples. Sebaceous lipid exposure induced extensive lipid droplet formation in macrophages through ACSL-dependent pathways, accompanied by functional reprogramming toward a pro-fibrotic phenotype. This transformation was accompanied by upregulation of transcription factors MafB and Maf, independent of canonical IL-4/STAT6 signaling. Macrophages with enhanced lipid droplet formation subsequently promoted fibroblast proliferation, enhanced collagen synthesis, and facilitated extracellular matrix remodeling through the CXCL8 signaling axis. In vivo validation using a sebaceous gland hyperplasia model confirmed increased collagen deposition and α-SMA expression associated with MafB+Maf+CD206+ macrophage accumulation.
conclusionsOur findings reveal that lipid droplet-mediated macrophage activation represents an important mechanism linking sebaceous lipid-rich microenvironments to fibrotic responses in keloid-associated inflammation. The identification of MafB- and Maf-regulated transcriptional programs and CXCL8-dependent macrophage-fibroblast crosstalk provides new therapeutic targets for preventing and treating keloid disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.